Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
Inavolisib has received regulatory approval for treating advanced luminal breast cancer in patients with a PIK3CA mutation. By specifically targeting the PI3K pathway, this therapy addresses a critical driver of ... Read More
Continuous Coverage
Mack Animation has officially unveiled SNORRI 4D – Catch Me If You Candy, a high-octane immersive film experience…
The Strategic Evolution of Combat Systems: Why Japanese Jiu-Jitsu Lost the Global Arena The original Japanese Jiu-Jitsu failed…
The total solar eclipse on August 12, 2026, represents a critical intersection of celestial mechanics and modern data-gathering…
Virgin Active’s Pivot Toward High-End Wellness as Consumer Spending Shifts Virgin Active, the international fitness operator, is aggressively…
As of mid-July 2026, the United States is managing a multi-state outbreak of cyclosporiasis, a gastrointestinal infection caused…
Tokyo’s Electric Revolution: Defining the Future of GEN4 Performance The Tokyo E-Prix has cemented its status as a…
Global Affairs
The United States government will impose a 25% tariff on approximately 3,000 Brazilian products starting July 22, 2026.…
Markets And Money
Porsche (ETR: P911) has officially debuted the new Cayenne Coupé Electric in Latvia, marking a calculated expansion of…
Digital Culture
)
Google has rebranded its NotebookLM research tool to Gemini Notebook, signaling a strategic consolidation of its generative AI…
Science And Wellbeing
Changes in nail morphology—the shape, texture, and color of your fingernails—can serve as early, objective biological indicators of…
Screen And Sound
A Violent Confrontation Over Queue Etiquette Highlights Urban Social Tension A man was hospitalized following a physical altercation…
Fixtures And Form
LSU Head Coach Lane Kiffin Faces Scrutiny Over $40,000 Private Jet Perk LSU football head coach Lane Kiffin…
